Key result
Perindopril treatment for 12 weeks significantly reduced mean sitting blood pressure from 156.9/94.5 mm Hg to 139.2/84.0 mm Hg, achieving blood pressure control in 48.8% of patients.
Why the study?
Does perindopril reduce blood pressure in US hypertensive patients?
Does perindopril reduce blood pressure in US hypertensive patients?
Perindopril monotherapy effectively reduces blood pressure and is well tolerated in a large community-based cohort of US hypertensive patients.
Answers are grounded in this paper and cite their sources.
Supports perindopril in US hypertensives; extends real-world data but leaves open randomized confirmation.
The authors evaluated, in a community‐based open‐label trial, the effectiveness and safety of perindopril in 13,220 US hypertensive patients and studied how physicians adhere to hypertension treatment guidelines. Patients received perindopril 4 mg q.d. for 6 weeks. Based on physicians' perception of blood pressure response, the patient was either maintained on 4 mg or the dose was increased to 8 mg for an additional 6 weeks. From baseline to week 12, the mean sitting blood pressure significantly declined from 156.9/94.5 mm Hg to 139.2/84.0 mm Hg. Further dose titration resulted in a clinically significant reduction in blood pressure in all patients with inadequate response on 4 mg at week 6. Blood pressure control (<140/<90 mm Hg) was achieved at 12 weeks in 48.8% patients. The subpopulation analyses demonstrated that perindopril monotherapy was effective in both men and women, in patients of all ethnicities, and in patients <65 and ≥65 years of age. Perindopril was safe and well tolerated in all hypertensive subgroups including high‐risk patients. Physicians were more attuned to controlling diastolic than systolic blood pressure, and their adherence to the treatment guidelines was found to be not optimal.
No takes yet. Share an insight, caveat, or question.
Julius et al. (2005) studied Hypertension (n=13,220). Perindopril was evaluated on Blood pressure control (<140/<90 mm Hg) at 12 weeks. Perindopril treatment for 12 weeks significantly reduced mean sitting blood pressure from 156.9/94.5 mm Hg to 139.2/84.0 mm Hg, achieving blood pressure control in 48.8% of patients.
Synapse has enriched 10 related papers. Consider them for comparative context: